Clinical trial Recruiting at 1 site Observational Ages 18 to 100

Using enteral (tube) feeding as recommended for adults with cancer.

Official title: Adherence to Enteral Nutrition

Run by Institut Curie · NCT07571564 · Data updated 2026-11-12

This project will see how well enteral (tube) feeding recommendations are followed by adults hospitalized for cancer who need enteral nutrition.

More Enteral Nutrition trials

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment80 (estimated)
SponsorInstitut Curie
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedMarch 5, 2026
Main results expectedSeptember 4, 2027
Study endsSeptember 4, 2027
Registry record updatedMay 6, 2026
Trial IDNCT07571564 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults hospitalized in the medical oncology unit at Institut Curie who are indicated for enteral nutrition by SFNCM/HAS criteria and who can consent and speak French.

Probably not a fit

Patients in end-of-life palliative care, minors, individuals under guardianship or judicial protection, those unable to participate for social or geographic reasons, and non–French speakers are excluded and will not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study at Institut Curie will review adult medical oncology inpatients for whom enteral nutrition is indicated and record whether care follows French HAS and SFNCM recommendations. Investigators will collect clinical and laboratory data, documentation of nutrition decisions, and the use of oral nutritional supplements versus enteral feeding during hospitalization. The protocol excludes minors, patients receiving end-of-life palliative care, those under legal protection, and patients who do not speak French. Results will be compared with prior audits (for example ADHENUTE) to identify gaps, barriers, and opportunities to improve guideline adherence.

Why it matters

Potential benefit: If practices are aligned with guidelines more consistently, patients could receive appropriate enteral nutrition earlier, helping reduce malnutrition and improve treatment tolerance and quality of life.

How similar studies have gone: Prior audits such as the ADHENUTE study have demonstrated low compliance (around 31%) with enteral nutrition recommendations, so comparable work has documented underuse rather than testing a new therapy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients hospitalized (including those in the day hospital) in a medical oncology unit;
* Adults;
* Men or women;
* Patients for whom enteral nutrition is indicated according to SFNCM recommendations;

Exclusion Criteria:

* Minors (under 18 years of age)
* Patients receiving end-of-life palliative care
* Individuals deprived of their liberty or under legal guardianship (including conservatorship);
* Adults under judicial protection;
* Inability to participate in the study for geographical, social, or psychological reasons.
* Persons referred to in Articles L. 1121-5 through L. 1121-8 and L. 1122-1-2 of the Public Health Code (e.g., minors, adults under guardianship, etc.).
* Patients who do not speak or understand French.

Where it's running

  • Institut Curie
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.